Stock screener

EBS

Conviction 18HealthcareScan · Thu, Sep 24, 2026

Emergent BioSolutions Inc. (EBS) closed at $6.76 (+1.35%) on Sep 24, 2026. Price is above its 50-day and below its 200-day moving average. RSI(14) 58, RS Rating 29, -51.4% from its 52-week high, -46.0% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

EBS$6.76+1.35%
ResistanceSupportVol 14Insider sellCongress buyCongress sell
63 bars
Vol MA14 1.28M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Emergent BioSolutions Inc.PHARMACEUTICAL PREPARATIONSwww.emergentbiosolutions.com ↗
Price6.76
Change+1.35%
Gap-0.45%
Rel volume0.85×
Avg volume1.23M
Avg $ vol7.84M
SMA 206.35
SMA 506.25
SMA 2008.75
Price vs 50+8.22%
Price vs 200-22.76%
MA stackmixed
50/200 cross—
Supertrendup · 5.86
RSI (14)58
MACD hist0.08
MACD cross—
Stoch %K / %D81 / 79
ADX (14)16
+DI / −DI24 / 21
RSI divergence—
MACD divergenceBearish
ATR %5.14%
ADR %5.26%
52w high13.90
52w low4.45
From 52w high-51.37%
Above 52w low+51.91%
New 52w highNo
SqueezeOff
Bollinger width22.70%
%B0.79
Donchian pos81.29%
Donchian high7.05
Donchian low5.50
AVWAP (52w high)8.03
vs AVWAP high-15.85%
AVWAP (52w low)5.64
vs AVWAP low+19.81%
OBV trendFlat
Chaikin MF (20)0.10
Today vs 20d0.85×
Avg vol (14d)1.28M
Avg vol (20d)1.23M
Avg $ vol (20d)7.84M
Market cap346.61M
RS Rating29 / 99
RS 3m (vs SPY)-19.78%
RS 6m (vs SPY)-34.48%
RS line new highNo
Trend template2/8
Technical rank46.5
1 week-3.70%
1 month+19.86%
3 months-15.29%
6 months-17.66%
1 year-17.36%
YTD-45.96%
P/E6.59
P/B1.02
P/S0.47
P/FCF2.21
EPS0.9300
Div yield—
ROE15.41%
ROA4.71%
Debt/Eq1.70
Current5.42
EV/EBITDA4.03
Gross margin42.75%
Net margin7.08%
Rev growth-28.81%
EPS growth127.60%
Price target10.00
Target upside47.93%
Analyst ratingBuy
Institutional95.23%
Ent. value788.71M
Revenue234.3M
Net income-180.2M
Gross profit161.2M
Free cash flow156.8M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNYSE
Shares out51.6M
Employees900
ListedWed, Nov 15, 2006
Free float50.61M
Float %98.0%
Short interest10.84M
Days to cover9.2d
Short volume59.3%
Squeeze score78 / 100
Next earnings—
EPS forecast—
Last EPS vs est$0.60
Last surprise—
Setup gradeD
Conviction18 / 100
Pattern quality—
Tech rank46.5 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance7.38
Support4.40
Days since event—
Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in EBS · 1 recent

All disclosures →
MemberSideAmount
Steve Cohen
Steve Cohen
house · D · TN · traded 2024-12-11
Sell$1K–$15K

Insider activity

SEC Form 4 transactions in EBS · open-market 6 sells

InsiderSideShares
Hartzel William
SVP, Bioservices · Common Stock · 2026-06-08
Tax1.74K
Williams Paul Anthony
SVP, Products Business · Common Stock · 2026-06-08
Tax694
LINDAHL RICHARD S
EVP, Chief Financial Officer · Common Stock · 2026-06-08
Tax3.96K
Glessner Coleen
EVP, Quality & Ethics, and CPL · Common Stock · 2026-06-08
Tax2.02K
Dayal Sujata Tyagi
Director · Common Stock · 2026-05-01
Sell980
Dayal Sujata Tyagi
Director · Common Stock · 2026-05-01
Sell12.78K
DeGolyer Donald W
Director · Common Stock · 2026-05-01
Sell954
DeGolyer Donald W
Director · Common Stock · 2026-05-01
Sell14.53K
Zoon Kathryn C
Director · Common Stock · 2026-05-01
Sell16.14K
Zoon Kathryn C
Director · Common Stock · 2026-05-01
Sell1.06K

SEC filings

EDGAR filings in EBS · 9 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.